Onesano S.A. Logo

Onesano S.A.

Develops patented nutritional products for humans, animals, and agriculture.

SKT | WAR

Overview

Corporate Details

ISIN(s):
PLSKTAN00010 (+1 more)
LEI:
259400O0ENJE93KANI38
Country:
Poland
Address:
CHORZÓW DYREKCYJNA 6, 41-506 CHORZÓW
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Onesano S.A. is a Polish biotechnology company specializing in the research, development, and production of innovative products for the full nutritional cycle. The company's portfolio includes natural dietary supplements for humans, animal nutrition products, and solutions for agriculture. Leveraging its own R&D laboratories and two production plants, Onesano develops proprietary, patented formulas and offers private label manufacturing services. The company, formerly known as Skotan S.A., operates an extensive distribution network and is committed to creating solutions that support human and planetary health through science-backed products.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 21:12
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 2.1 KB
2025-09-04 18:30
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 1.2 KB
2025-09-03 20:48
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 2.7 KB
2025-08-14 17:20
Interim Report
onesano_SA_raport_polroczny_IH2025
Polish 2.3 MB
2025-08-14 17:20
Audit Report / Information
RAPORT_przegląd_IH2025
Polish 241.4 KB
2025-08-11 21:43
Registration Form
Statut_onesano_SA_po_rejestracji_w_dn.11.08.2025
Polish 515.2 KB
2025-08-11 21:43
Governance Information
Rejestracja zmian Statutu Spółki - Content (PL)
Polish 6.7 KB
2025-06-30 18:17
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy dysponujących co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 539 bytes
2025-06-30 18:07
Board/Management Information
Życiorys-członka-RN-onesano-JBlaszczak
Polish 278.7 KB
2025-06-30 18:07
Board/Management Information
Powołanie osoby nadzorującej - Content (PL)
Polish 2.2 KB
2025-06-30 17:55
Registration Form
onesano_Zalacznik_do_uchwaly_nr_18_ZWZ_30.06.2025
Polish 515.1 KB
2025-06-30 17:55
Remuneration Information
onesano_Sprawozdanie_Rady_Nadzorczej_o_wynagrodzeniach_za_2024r.
Polish 1.2 MB
2025-06-30 17:55
Board/Management Information
onesano_Sprawozdanie_RN_z_dzialalnosci_w_2024r.
Polish 1.3 MB
2025-06-30 17:55
Post-Annual General Meeting Information
onesano_Uchwaly_ZWZ_30.06.2025
Polish 528.0 KB
2025-06-30 17:55
Post-Annual General Meeting Information
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie onesano S.A. w dniu 30 czerw…
Polish 911 bytes

Automate Your Workflow. Get a real-time feed of all Onesano S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Onesano S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Onesano S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.